Genes in panel
STRs in panel
Prev Next

Early onset or syndromic epilepsy

Gene: SATB2

Green List (high evidence)

SATB2 (SATB homeobox 2)
EnsemblGeneIds (GRCh38): ENSG00000119042
EnsemblGeneIds (GRCh37): ENSG00000119042
OMIM: 608148, Gene2Phenotype
SATB2 is in 7 panels

3 reviews

Arina Puzriakova (Genomics England Curator)

Green List (high evidence)

The rating of this gene has been updated to Green following NHS Genomic Medicine Service approval.
Created: 11 Oct 2023, noon | Last Modified: 11 Oct 2023, noon
Panel Version: 4.110

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Sarah Leigh (Genomics England Curator)

Green List (high evidence)

Associated with Glass syndrome, OMIM:612313 and as definitive Gen2Phen gene for the same condition. Table 2 in PMID: 32446642 presents a clincal review of SATB2 variant carriers. Amongst the 35 cases carrying intragenic variants, 14 did not have clinical seizures, 19 had seizures (10 well controlled, 9 somewhat controlled) and the diagnosis was uncertain in two other cases.
Created: 14 Mar 2023, 6:11 p.m. | Last Modified: 14 Mar 2023, 6:11 p.m.
Panel Version: 3.113
Comment on list classification: There is enough evidence for this gene to be rated GREEN at the next major review.
Created: 14 Mar 2023, 5:37 p.m. | Last Modified: 14 Mar 2023, 5:37 p.m.
Panel Version: 3.112

Zornitza Stark (Australian Genomics)

In a cohort of 101 individuals with SATB2-associated syndrome, 41 had at least one prior abnormal EEG. Thirty-eight individuals (93%) had epileptiform discharges, 28 (74%) with central localization. Sleep stages were included as part of the electroencephalographies performed in 31 individuals (76%), and epileptiform activity was recorded during sleep in all instances (100%). Definite clinical seizures were diagnosed in 17 individuals (42%) with a mean age of onset of 3.2 years (four months to six years), and focal seizures were the most common type of seizure observed (42%). Six individuals with definite clinical seizures needed polytherapy (35%).
Sources: Literature
Created: 2 Nov 2020, 9:36 a.m.

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
Glass syndrome, MIM# 612313

Publications

Variants in this GENE are reported as part of current diagnostic practice

Details

Mode of Inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Sources
  • Expert Review Green
  • NHS GMS
Phenotypes
  • Glass syndrome, OMIM:612313
OMIM
608148
Clinvar variants
Variants in SATB2
Penetrance
None
Publications
Panels with this gene

History Filter Activity

11 Oct 2023, Gel status: 3

Removed Tag

Arina Puzriakova (Genomics England Curator)

Tag Q1_23_promote_green was removed from gene: SATB2.

11 Oct 2023, Gel status: 3

Added New Source, Added New Source, Status Update

Arina Puzriakova (Genomics England Curator)

Source NHS GMS was added to SATB2. Source Expert Review Green was added to SATB2. Rating Changed from Amber List (moderate evidence) to Green List (high evidence)

14 Mar 2023, Gel status: 2

Set Phenotypes

Sarah Leigh (Genomics England Curator)

Phenotypes for gene: SATB2 were changed from Glass syndrome, MIM# 612313 to Glass syndrome, OMIM:612313

14 Mar 2023, Gel status: 2

Added Tag

Sarah Leigh (Genomics England Curator)

Tag Q1_23_promote_green tag was added to gene: SATB2.

14 Mar 2023, Gel status: 2

Entity classified by Genomics England curator

Sarah Leigh (Genomics England Curator)

Gene: satb2 has been classified as Amber List (Moderate Evidence).

2 Nov 2020, Gel status: 0

Created, Added New Source, Set mode of inheritance, Set publications, Set Phenotypes

Zornitza Stark (Australian Genomics)

gene: SATB2 was added gene: SATB2 was added to Genetic epilepsy syndromes. Sources: Literature Mode of inheritance for gene: SATB2 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Publications for gene: SATB2 were set to 32446642 Phenotypes for gene: SATB2 were set to Glass syndrome, MIM# 612313 gene: SATB2 was marked as current diagnostic